Skip to main content

Latest SEC Filings — Page 26

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Activist STARTEEPO Raises Xerox Stake to 7.34% and Demands Strategic Review of XFS Unit
ProForm SCHEDULE 13D/AXRX · Form SCHEDULE 13D/A · 5d ago
Collective Mining to Release Maiden Apollo Mineral Resource After Market Close; Call Sept 9
Form 6-KCNL · Form 6-K · 5d ago
Imfinzi + Imdelltra Hits OS Endpoint in Phase III ES-SCLC Trial
ProForm 6-KAZN · Form 6-K · 5d ago
GameStop Posts Record Q2 Operating Income, Raises FY26 EBITDA Outlook to $650M+
ProForm 8-KGME · Form 8-K · 5d ago
Genpact Names Sumita Pandit CFO; Michael Weiner Steps Down After Transition
Form 8-KG · Form 8-K · 5d ago
Pharvaris CHAPTER-3 Data: 83% Attack Reduction, All Secondary Endpoints Met
ProForm 6-KPHVS · Form 6-K · 5d ago
HCW Biologics Signs Exclusive Distribution Deal with Akron Biotech for HCW11-006 Reagent
Form 8-KHCWB · Form 8-K · 5d ago
Qualcomm Grants Amazon Warrant for 25M Shares Linked to $60B Server Chip Agreement
ProForm 8-KQCOM · Form 8-K · 5d ago
EMAT Registers 7.5M Shares for Yorkville Resale; $6.8M of Debentures Already Converted
Form S-1EMAT · Form S-1 · 5d ago
Bitmine Swaps Staking Manager for Lower-Fee American Validator Deal
Form 8-KBMNR · Form 8-K · 5d ago
Eagle Financial to Merge with John Marshall Bancorp in $253M All-Stock Deal
ProForm 8-KEFSI · Form 8-K · 5d ago
John Marshall Bancorp to Acquire Eagle Financial Services in $253M All-Stock Merger
ProForm 8-KJMSB · Form 8-K · 5d ago
GoPro Issues $20M Convertible Debenture to Yorkville at Deep Discount
ProForm 8-KGPRO · Form 8-K · 5d ago
Elmet Group Signs Definitive Agreement to Acquire ams OSRAM's German Tungsten and Molybdenum Operations
ProForm 8-KELMT · Form 8-K · 5d ago
PDS Biotech Secures $22.55M PIPE Led by Dr. Patrick Soon-Shiong, Gains Board Seats and PDS0101 Option
ProForm 8-KPDSB · Form 8-K · 5d ago
GlobalFoundries to Issue 9.9M Shares to U.S. Commerce Department at $37.85
Form 6-KGFS · Form 6-K · 5d ago
Markel Chairman Steve Markel to Retire; CEO Tom Gayner Adds Chairman Role
Form 8-KMKL · Form 8-K · 5d ago
Veru Redirects Sabizabulin to Daraxonrasib-Resistant Pancreatic Cancer After Encouraging Preclinical Results
Form 8-KVERU · Form 8-K · 5d ago
GRI Bio Unveils Phase 2a Biomarker Data Showing Repair Phenotype in IPF
ProForm 8-KGRI · Form 8-K · 5d ago
Health Catalyst Appoints Simeon Kohl as CEO; Ben Albert Moves to Chief Business Officer
ProForm 8-KHCAT · Form 8-K · 5d ago
Positive Phase 1/2a and 72-Week OLE Data Reported Across Oral Amylin and GLP-1 Programs
ProForm 8-KGPCR · Form 8-K · 5d ago
Doncasters Completes $325M Debt Refinancing, Replacing Pre-IPO Facilities
Form 8-KDPC · Form 8-K · 5d ago
SPY003 Hits Primary Endpoint in Phase 2 SKYLINE Trial, Completing Proof-of-Concept for All Three IBD Components
ProForm 8-KSYRE · Form 8-K · 5d ago
Cresud FY2026 Net Income Rises 24% to ARS 372.3B on Record Grain Output
Form 6-KCRESY · Form 6-K · 5d ago
Trade Desk Seeks Stockholder Approval to Reprice 16.9M Underwater Options
Form PRE 14ATTD · Form PRE 14A · 5d ago
Garden Stage Shareholders Approve 20x Increase in Authorized Class A Shares
Form 6-KGSIW · Form 6-K · 5d ago
Adlai Nortye Doses First Patient in AN4035 Phase I Trial, Secures U.S. FDA IND Clearance
Form 6-KANL · Form 6-K · 5d ago
Longevity Health Secures Up to $625K Convertible Note Facility with Puritan Partners
Form 8-KXAGEW · Form 8-K · 5d ago
Strategy Doubles Digital Credit Repurchase Authorization to $2B, Buys Back $176M of STRC
Form 8-KMSTR · Form 8-K · 5d ago
FDA Grants Second Breakthrough Therapy Designation for DT120 in Major Depressive Disorder
ProForm 8-KDFTX · Form 8-K · 5d ago